The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

Author(s):
Brooks, S.; Siebenga, P.; Zuiker, R.; Jacobs, G.; Kezic, I.; Gerven, J. van; Luthringer, R.; Boer, P. de; Ark, P. van der
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-31
Language
English
Is part of
European Neuropsychopharmacology (2017), Vol. 27, p. S655-S656
hdl
1887/116423